Variants of Insulin-Signaling Inhibitor Genes in Type 2 Diabetes and Related Metabolic Abnormalities
Open Access
- 23 May 2013
- journal article
- review article
- Published by Wiley in International Journal of Genomics
- Vol. 2013, 1-13
Abstract
Insulin resistance has a central role in the pathogenesis of several metabolic diseases, including type 2 diabetes, obesity, glucose intolerance, metabolic syndrome, atherosclerosis, and cardiovascular diseases. Insulin resistance and related traits are likely to be caused by abnormalities in the genes encoding for proteins involved in the composite network of insulin-signaling; in this review we have focused our attention on genetic variants of insulin-signaling inhibitor molecules. These proteins interfere with different steps in insulin-signaling: ENPP1/PC-1 and the phosphatases PTP1B and PTPRF/LAR inhibit the insulin receptor activation; INPPL1/SHIP-2 hydrolyzes PI3-kinase products, hampering the phosphoinositide-mediated downstream signaling; and TRIB3 binds the serine-threonine kinase Akt, reducing its phosphorylation levels. While several variants have been described over the years for all these genes, solid evidence of an association with type 2 diabetes and related diseases seems to exist only for rs1044498 of theENPP1gene and for rs2295490 of theTRIB3gene. However, overall the data recapitulated in this Review article may supply useful elements to interpret the results of novel, more technically advanced genetic studies; indeed it is becoming increasingly evident that genetic information on metabolic diseases should be interpreted taking into account the complex biological pathways underlying their pathogenesis.Keywords
This publication has 114 references indexed in Scilit:
- Gene-Environment Interactions in Genome-Wide Association Studies: A Comparative Study of Tests Applied to Empirical Studies of Type 2 DiabetesAmerican Journal of Epidemiology, 2011
- The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β cellsJournal of Clinical Investigation, 2010
- MammalianTribbleshomolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han ChinesePLOS Genetics, 2010
- IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variantsDiabetologia, 2009
- The Association ofENPP1K121Q with Diabetes Incidence Is Abolished by Lifestyle Modification in the Diabetes Prevention ProgramThe Journal of Clinical Endocrinology & Metabolism, 2009
- TheTRIB3Q84R Polymorphism and Risk of Early-Onset Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2009
- Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesNature Genetics, 2008
- The Role of Membrane Glycoprotein Plasma Cell Antigen 1/Ectonucleotide Pyrophosphatase Phosphodiesterase 1 in the Pathogenesis of Insulin Resistance and Related AbnormalitiesEndocrine Reviews, 2008
- Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertensionJournal of Medical Genetics, 2007